Dimiter S. Dimitrov mainly focuses on Virology, Antibody, Immunology, Monoclonal antibody and Epitope. In most of his Virology studies, his work intersects topics such as Glycoprotein. Dimiter S. Dimitrov focuses mostly in the field of Antibody, narrowing it down to matters related to Acquired immunodeficiency syndrome and, in some cases, Human disease, Immune correlates and Antibody response.
As a member of one scientific family, Dimiter S. Dimitrov mostly works in the field of Immunology, focusing on Internal medicine and, on occasion, Gastroenterology, Lymphopoiesis and CD28. His study in the field of Antibodies monoclonal is also linked to topics like Paradigm shift. He has researched Epitope in several fields, including Immunoglobulin G, Viral envelope, Avidity and Peptide library.
His primary areas of study are Antibody, Virology, Monoclonal antibody, Molecular biology and Epitope. His research in Antibody tackles topics such as Antigen which are related to areas like Cancer research and T cell. His Virology research incorporates themes from Gp41, Immunology and Glycoprotein.
His Monoclonal antibody research incorporates elements of Hendra Virus, Biochemistry, Phage display and Peptide library. The study incorporates disciplines such as Protein structure, Cell culture, Plasma protein binding and Cell in addition to Molecular biology. The concepts of his Epitope study are interwoven with issues in Neutralizing antibody and Germline.
His primary scientific interests are in Antibody, Cancer research, Virology, Monoclonal antibody and Antigen. His Antibody study combines topics from a wide range of disciplines, such as Biochemistry, Glycoprotein and Mutant. His Cancer research study combines topics in areas such as Cancer cell, Cancer, Pediatric cancer, Immunotherapy and Neuroblastoma.
His work in the fields of Virus, Henipavirus and Hendra Virus overlaps with other areas such as Severe acute respiratory syndrome coronavirus 2. His Monoclonal antibody research is multidisciplinary, incorporating perspectives in Panning and Fusion protein. His research investigates the connection with Antigen and areas like Chimeric antigen receptor which intersect with concerns in CD22, Leukemia, CD33, Myeloid leukemia and Molecular biology.
Dimiter S. Dimitrov spends much of his time researching Antibody, Antigen, Virology, Monoclonal antibody and Neutralization. His work investigates the relationship between Antibody and topics such as Glycoprotein that intersect with problems in Potency. The various areas that Dimiter S. Dimitrov examines in his Antigen study include Immunohistochemistry, Molecular biology, Myeloid leukemia and Chimeric antigen receptor, Immunotherapy.
His Virology research focuses on In vitro and how it connects with Panning. His research in Monoclonal antibody intersects with topics in Epitope, Virus, Germline and Dengue fever. His Neutralization research integrates issues from Host cell membrane, Hendra Virus, Henipavirus Infections, Henipavirus and Peptide library.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Structural definition of a conserved neutralization epitope on HIV-1 gp120.
Tongqing Zhou;Ling Xu;Barna Dey;Ann J. Hessell.
Structure of a V3-Containing HIV-1 gp120 Core
Chih-chin Huang;Min Tang;Mei-Yun Zhang;Shahzad Majeed.
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
Richard T. Davey;Niranjan Bhat;Christian Yoder;Tae Wook Chun.
Proceedings of the National Academy of Sciences of the United States of America (1999)
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.
Terry J Fry;Nirali N Shah;Rimas J Orentas;Maryalice Stetler-Stevenson.
Nature Medicine (2018)
Evaluation of gene expression measurements from commercial microarray platforms
Paul K. Tan;Thomas J. Downey;Edward L. Spitznagel;Pin Xu.
Nucleic Acids Research (2003)
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
Leonid Cherkassky;Aurore Morello;Jonathan Villena-Vargas;Yang Feng.
Journal of Clinical Investigation (2016)
Quantitation of human immunodeficiency virus type 1 infection kinetics.
D. S. Dimitrov;R. L. Willey;H. Sato;Lung-Ji Chang.
Journal of Virology (1993)
Virus entry: molecular mechanisms and biomedical applications
Dimiter S. Dimitrov.
Nature Reviews Microbiology (2004)
Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
Waleed Haso;Daniel W. Lee;Nirali N. Shah;Maryalice Stetler-Stevenson.
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
Masashi Shingai;Yoshiaki Nishimura;Florian Klein;Hugo Mouquet.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: